Showing results (591-600 of 661) with videos related to

Sort By:
Pageof 67
Radiation Oncology (London, England)|December 14, 2020
Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancerPrashant Vempati, Aditya N Halthore, Sewit Teckie, et al.
BMC Medical Education|March 3, 2023
Radical reform of the undergraduate medical education program in a developing country: the Egyptian experienceNadia Badrawi, Somaya Hosny, Lamis Ragab, et al.
Scientific Reports|August 2, 2018
High Dose Vitamin D supplementation alters faecal microbiome and predisposes mice to more severe colitisSimon Ghaly, Nadeem O Kaakoush, Frances Lloyd, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 28, 2025
Renoprotective effect of dulaglutide in L-NAME-induced hypertensive nephropathy in rats: insight into the roles of PPAR-gamma and VEGFNermeen Bastawy, Aliaa E M K El-Mosallamy, Rabab Ahmed Rasheed, et al.
Archives of Andrology|August 1, 1983
Endocrine profiles in pediatric andrology. II. Insulin-dependent diabetic adolescentsI I Ibrahim, R Sakr, I M Ghaly, et al.
The International Journal of Cardiovascular Imaging|March 22, 2025
Prognostic value of baseline RV dysfunction using TAPSE and TAPSE to PASP ratio in patients undergoing mitra-clip: a systematic review and meta-analysisAnan Abu Rmilah, Ramy Ghaly, Carlos Pfeiffer, et al.
Inflammatory Bowel Diseases|January 20, 2024
Dietary Emulsifier Exposure in People With Inflammatory Bowel Disease Compared With Healthy Controls: Is There a Cause for Concern?Natasha Katsoudas, Paris Tavakoli, Nan Wu, et al.
Brachytherapy|February 25, 2026
Improving complex brachytherapy efficiency: Multidisciplinary quality assurance and workflow optimizationAndrew Gross, Xue Wu, Ming Wang, et al.
British Journal of Biomedical Science|April 4, 2017
Circulating levels of collagen III and MMP-1 in patients with chronic hepatitis C co-infected with hepatitis B virusAbdelfattah M Attallah, Mohamed El-Far, Mohamed F Ghaly, et al.
Internal Medicine Journal|November 6, 2014
Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of responseS Ghaly, S Costello, L Beswick, et al.
Pageof 67